Tamoxifen's Effects on Women's Reproductive Health
Author Information
Author(s): Nasu Kaei, Takai Noriyuki, Nishida Masakazu, Narahara Hisashi
Primary Institution: Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan
Hypothesis
Does prolonged tamoxifen treatment increase the risk of gynecological complications in women?
Conclusion
Tamoxifen is associated with an increased incidence of benign endometrial lesions and a two- to four-fold increased risk of endometrial cancer in postmenopausal patients.
Supporting Evidence
- Tamoxifen increases the risk of benign endometrial lesions such as polyps and hyperplasia.
- Postmenopausal patients on tamoxifen have a two- to four-fold increased risk of endometrial cancer.
- Functional ovarian cysts are significantly more common in premenopausal tamoxifen users.
Takeaway
Tamoxifen can help treat breast cancer, but it may also cause problems in women's reproductive organs, especially in older women.
Methodology
This review analyzes clinical data on the effects of tamoxifen on the female genital tract.
Limitations
The review does not provide specific data on the sample sizes or the methodologies of the studies referenced.
Participant Demographics
The review discusses effects primarily in premenopausal and postmenopausal women.
Want to read the original?
Access the complete publication on the publisher's website